PROK PEER ANALYSIS

ProKidney Corp. — metric-by-metric comparison with peers and the industry median

PROKProKidney Corp.

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

PROKIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PROK	MSB	RTALB	TLX	Ind. Median
P/E	—	—	4.78	—	18.06
P/B	-0.27●	—	0.59	6.38	3.62
EV/EBITDA	—	—	72.98●	120.20	15.13
P/S	311.31	31.30	6.52	3.24●	10.65

Financial Health
Metric	PROK	MSB	RTALB	TLX	Ind. Median
Current Ratio	9.06●	—	1.21	1.43	5.90
Debt/Equity	-0.4%●	—	1.2%	112.3%	10.9%
NetDebt/EBITDA	1.47	—	0.90●	13.13	1.15

Profitability
Metric	PROK	MSB	RTALB	TLX	Ind. Median
Net Margin	-8,418.0%	-115.3%	136.3%●	-0.9%	-125.7%
ROE	—	-11.3%	15.1%●	-1.8%	-47.5%
ROA	-21.4%	-8.6%	13.1%●	-0.7%	-35.8%
EBITDA Margin	-16,919.8%	-76.6%	9.0%●	3.0%	-105.8%

Growth + Dividend
Metric	PROK	MSB	RTALB	TLX	Ind. Median
Rev. Growth	190.5%	410.4%●	24.0%	56.3%	5.1%
NI Growth	—	—	134.0%	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	PROK	MGNX	LRMR	LYEL	OABI	ZNTL	Ind. Median
P/E	—	—	—	—	—	—	18.06
P/B	-0.27●	14.22	1.84	1.27	1.13	1.84	3.62
EV/EBITDA	—	—	—	—	—	—	15.13
P/S	311.31	1.92●	—	11,227.33	10.30	—	10.65

Financial Health
Metric	PROK	MGNX	LRMR	LYEL	OABI	ZNTL	Ind. Median
Current Ratio	9.06●	1.90	4.29	7.23	4.80	6.19	5.90
Debt/Equity	-0.4%●	172.2%	2.4%	17.9%	7.5%	21.2%	10.9%
NetDebt/EBITDA	1.47	2.32	1.19	0.86●	0.87	1.32	1.15

Profitability
Metric	PROK	MGNX	LRMR	LYEL	OABI	ZNTL	Ind. Median
Net Margin	-8,418.0%	-44.8%●	—	-794,858.1%	-187.7%	—	-125.7%
ROE	—	-140.3%	-109.8%	-80.8%	-20.2%●	-51.9%	-47.5%
ROA	-21.4%	-31.8%	-87.7%	-63.1%	-18.1%●	-39.0%	-35.8%
EBITDA Margin	-16,919.8%	-32.2%●	—	-770,932.3%	-117.0%	—	-105.8%

Growth + Dividend
Metric	PROK	MGNX	LRMR	LYEL	OABI	ZNTL	Ind. Median
Rev. Growth	190.5%●	3.1%	-100.0%	-52.3%	8.1%	-100.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PROK

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.